Navigation Links
Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter
Date:11/23/2009

POINT RICHMOND, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application (NDA) for Intermezzo® (zolpidem tartrate sublingual tablet). As previously announced, the Complete Response Letter, received by Transcept on October 28, 2009, indicated that the FDA could not approve the NDA in its present form. The NDA seeks approval to market Intermezzo® for use as-needed for the treatment of insomnia when a middle of the night awakening is followed by difficulty returning to sleep.

Following the receipt of official FDA minutes of the meeting, Transcept plans to provide an update on its discussions with the FDA and the status of the anticipated Intermezzo® NDA resubmission.

About Transcept Pharmaceuticals, Inc.

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. The most advanced Transcept product candidate is Intermezzo® (zolpidem tartrate sublingual tablet), for which a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) in September 2008 seeking approval as a prescription sleep aid for use in the middle of the night at the time a patient awakens and has difficulty returning to sleep. In October 2009 Transcept received a Complete Response Letter from the FDA on the Intermezzo® NDA in which the FDA stated that it could not approve the NDA in its present form. Transcept is working to respond to issues raised in the letter. Transcept and Purdue
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results
2. Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17
3. Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12
4. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
5. Transcept Pharmaceuticals to Report First Quarter 2009 Results
6. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
7. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
8. Sagent Pharmaceuticals to Present at Piper Jaffray Health Care Conference
9. Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
10. Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
11. AUDIO from Medialink and Ortho-McNeil-Janssen Pharmaceuticals Inc.: Getting Ready for Cold and Flu Season
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... VIEW, Calif., March 5, 2015  IRIDEX Corporation (Nasdaq: ... quarter and year ended January 3, 2015.  , ... a record for the Company and up 11% from $10.6 ... $42.8 million, also a record, up 12% from $38.3 million ... quarter was 50.1%, up from 48.6% in the fourth quarter ...
(Date:3/5/2015)... -- BioPhotas, Inc., an FDA registered medical device manufacturer selling ... treat skin, muscle and joint conditions, today announced that ... provide BioPhotas, flagship product, the Celluma, to ... Commenting on the alliance, Patrick Johnson ... at the Warrior Hope and Care Center had suffered ...
(Date:3/5/2015)... March 5, 2015   ndd Medical Technologies , ... that employs precise ultrasound technology, announced that its EasyOne ... by the San Antonio Pulmonary Fibrosis Support Group. The ... pulmonary fibrosis (PF), as well as those suspected of ... of a mere 12 square inches, EasyOne Pro provides ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3
(Date:3/5/2015)... Battle Creek, Michigan (PRWEB) March 05, 2015 ... celebrates the opportunity to shatter myths about drug and ... Forever Recovery has released a Fact Sheet with information ... substance abuse. Launched in 2010 by the National Institute ... about drugs and alcohol aims to counteract the illusions ...
(Date:3/5/2015)... Califia Farms , the fastest-growing natural ... coffee drinks category[1], today unveils its new Concentrated Cold ... Calif. Concentrated Cold Brew (CCB) is the centerpiece ... the next wave of the coffee-taste evolution by giving ... their own baristas. , Califia Farms CCB has ...
(Date:3/5/2015)... York, NY (PRWEB) March 05, 2015 ... orthopedic Surgeon ( http://www.orthopedicsurgeonnyc.com ) has been named by ... the New York Metro area. Dr. Glashow has been ... its authoritative guide to the top specialty care doctors ... , The prestigious Castle Connolly program, which carefully screens ...
(Date:3/5/2015)... Indialantic, FL (PRWEB) March 05, 2015 ... sports nutrition products, is pleased to offer reformulated Millennium ... official website, Millennium 500 is a German grade creatine ... muscle hydration, promote muscle recovery, and aid with overall ... occurring compound that acts as a reserve energy source ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Wimbledon ... which provides vascular, echocardiogram and NCV testing, ... as the Chief Medical Officer. Dr. Artel will be ... development of the WimbledonMED program and the continued growth ... passionate about working with Wimbledon Health Partners as a ...
Breaking Medicine News(10 mins):Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:Dr. Jonathan Glashow, NYC Orthopedic Surgeon, Named Top Doctor: New York Metro Area 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 2Health News:Wimbledon Health Partners Appoints Chief Medical Officer to Attain Medicare Market Share 3
... Ky. (Aug. 12, 2009) − Meal replacements in a ... weight loss, according to a new study conducted at ... August 2009 issue of the Journal of the ... products of Health Management Resources Corporation (HMR), a privately ...
... , , TAMPA, ... it is showing its support for National Health Center Week (August ... centers across the country throughout the week through its ProjectSERVS (Sage ... National Health Center Week is an annual celebration designed to raise ...
... ... ... poly-L-lactic acid filler previously approved for loss of facial fat in HIV positive individuals, ... and contours. "Sculptra offers a very different approach to treating the aging face," says ...
... mental and physical health, experts say , WEDNESDAY, Aug. 12 ... stress is the prime reason, a new study reports. , ... worries about school and life keep them awake, with one-fifth saying ... online in the Journal of Adolescent Health , found that ...
... Universal healthcare, touted as a way to make healthcare ... U.S. residents uninsured. Animal, livestock and pet owners are ... livestock and animals , , BATON ROUGE, La., ... , Here are the facts, most Americans have health ...
... , , FT. LAUDERDALE, Fla., ... that more than 50 percent of the adult population in the US ... of benefits of weight loss are improved self-esteem, social acceptance, and a ... is the only way to achieve long-term, sustainable weight loss for most ...
Cached Medicine News:Health News:UK study finds meal replacements aid weight loss 2Health News:Sage Software Healthcare, Inc. Celebrates National Health Center Week 2Health News:Cosmetic Use of Sculptra Now FDA Approved 2Health News:Cosmetic Use of Sculptra Now FDA Approved 3Health News:Cosmetic Use of Sculptra Now FDA Approved 4Health News:Stressed Out College Students Losing Sleep 2Health News:Members of Over 71 Million U.S. Households Ignored by Universal Healthcare 2Health News:Members of Over 71 Million U.S. Households Ignored by Universal Healthcare 3Health News:Members of Over 71 Million U.S. Households Ignored by Universal Healthcare 4Health News:Zimmerman Travels Across Country for $10M Weight Loss 2Health News:Zimmerman Travels Across Country for $10M Weight Loss 3
... The Featured Products are ... Mediflex and are offered ... in regular or extra ... equipped with insulation, flush ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
... incorporate a layered design unique in the ... to prevent stray electrosurgical burns along the ... failure or capacitive coupling; a well-documented patient ... all AEM Instruments provides a neutral return ...
Medicine Products: